Health Scan: Genetic mutation affects ovaries

The idea for the study surfaced when Dr. de Vries was asked to treat two POI patients, daughters of two sets of Israeli-Arab parents who were related to each other.

By
January 31, 2015 23:53
2 minute read.
Tel Aviv University campus

Tel Aviv University campus. (photo credit: PR)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Tel Aviv University researchers have discovered a cause for premature (primary) ovarian insufficiency (POI) in women under the age of 40. The condition affects one percent of all younger women worldwide. In most cases, the exact cause of the condition, which is often associated with infertility, is difficult to determine.

The previously-unidentified cause of POI is a unique mutation in a gene called SYCE1 that has not been previously associated with POI in humans (although it had been in animal models). The research, published recently in the Journal of Clinical Endocrinology and Metabolism, was led by Dr. Liat de Vries and Prof. Lina Basel-Vanagaite of TAU’s Sackler Faculty of Medicine and Schneider Children’s Medical Center in Petah.

Be the first to know - Join our Facebook page.


“Researchers know that POI may be associated with Turner’s syndrome, a condition in which a woman has only one X chromosome instead of two; it could also be due to toxins like chemotherapy and radiation therapy,” said de Vries. “However, in 90% of the cases, the exact cause remains a mystery.”

The idea for the study surfaced when Dr. de Vries was asked to treat two POI patients, daughters of two sets of Israeli-Arab parents who were related to each other. The girls presented with typical POI symptoms: one had the appearance of puberty but had not gotten her period, and the other one had not started puberty at all. After ruling out the usual suspects (toxins, autoimmune disease and known chromosomal and genetic diseases), the researchers set out to identify the genetic cause of POI in the two young women.

“One of my main topics of interest is puberty,” said de Vries. “The clinical presentation of the two sisters, out of 11 children of first-degree cousins, was interesting. In each of the girls, POI was expressed differently. One had reached puberty and was almost fully developed but hadn’t had periods. The second, 16 years old, showed no signs of development whatsoever.”

The researchers performed genotyping in the patients, their parents and siblings; this revealed a mutation that results in nonfunctional protein product in the SYCE1 gene in both affected sisters. The parents and three brothers were found to be carriers of the mutation, and an unaffected sister did not carry the mutation.

“By identifying the genetic mutation, we saved the family a lot of heartache by presenting evidence that any chance of inducing fertility in these two girls is slight,” said de Vries. “As bad as the news is, at least they will not spend years on fertility treatments and will instead invest efforts in acquiring an egg donation, for example. Knowledge is half the battle – and now, all family members know they should undergo genetic testing for this mutation.”



The researchers are currently investigating evidence of the effects of this genetic mutation on male members of the family.

“We are trying to get more family members tested, but it is not always easy in traditional societies. There is still a lot to be done on this subject,” she concluded.

Related Content

August 21, 2018
‘Foxtrot,’ ‘Longing’ get European Film Award nods

By AMY SPIRO